NCT05623241

Brief Summary

Evaluation of the diagnostic accuracy of Mammography in the morpho-structural analysis of mammographic images in breast cancer-diagnosed patients or patients in follow-up for breast cancer by extracting a number of features describing the texture and morphology of the lesions reported in the form of a structured report explicitly developed for the study. Correlation of the data obtained from evaluating the primary endpoint with the genetic/molecular analysis on liquid biopsy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 21, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2025

Completed
Last Updated

November 21, 2022

Status Verified

November 1, 2022

Enrollment Period

1 year

First QC Date

November 12, 2022

Last Update Submit

November 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiomic of breast cancers and liquid biopsy

    Detect possible relationships between breast cancers radiomic feature and genetic mutations on liquid biopsy

    36 months

Interventions

Liquid BiopsyDIAGNOSTIC_TEST

Venous blood sampling for liquid biopsy in breast cancer patients after segmentation of the lesion on mammography

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPatients are enrolled in mammography screening
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The liquid biopsy will be performed on all patients who undergo a mammography examination in which a malignant focal aspect has been found and who agree to participate in the study. All patients enrolled in the study will be subjected to a peripheral venous blood sample. The ctDNA will be extracted for molecular analysis and will be performed with NGS (Next Generation Sequencing) technology.

You may qualify if:

  • full information on the study and signature of the informed consent
  • biopsy-proven breast cancer or previous surgery for breast cancer
  • willingness of the patient to undergo liquid biopsy

You may not qualify if:

  • state of pregnancy or breastfeeding
  • patients operated on for benign or inflammatory diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University "Luigi Vanvitelli"

Naples, 80127, Italy

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Liquid Biopsy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

BiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

November 12, 2022

First Posted

November 21, 2022

Study Start

September 12, 2022

Primary Completion

September 15, 2023

Study Completion

September 22, 2025

Last Updated

November 21, 2022

Record last verified: 2022-11

Locations